Yumei Zhu

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Health Insurance

Radiation Therapy

Top Venues

Expert review of pharmacoeconomics & outcomes research

The International journal of health planning and management

China Pharmaceutical University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

China Pharmaceutical University Nov 01 2019

China

Lecturer :: School of International Pharmaceutical Business

Publications

Zhiguang Yang, Yumei Zhu, Guiyuan Xiang, Tiantian Hua, Jun Ni, Jie Zhao, Yun Lu, Yingyu Wu, Feng Chang
First-line atezolizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer: a cost-effectiveness analysis from China. Expert review of pharmacoeconomics & outcomes research 21 (5) (2021)
Xuan Chen, Zhiguang Yang, Guiyuan Xiang, Lingna Gu, Ziheng Qi, Bin Wan, Yun Lu, Feng Chang, Yumei Zhu
Durvalumab consolidation therapy in patients with stage III non-small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis. Expert review of pharmacoeconomics & outcomes research (2021)
Yumei Zhu, August Österle
China's policy experimentation on long-term care insurance: Implications for access. The International journal of health planning and management 34 (4) (2019)